BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27876435)

  • 1. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 2. Supramolecular Nanotheranostics.
    Chen X; Zheng G; Cheng J; Yang YY
    Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 4. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy.
    Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J
    ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Molecular Machines in Nanotheranostics.
    Yu G; Yung BC; Zhou Z; Mao Z; Chen X
    ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
    Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
    Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanohybrids - cancer theranostics for tiny tumor clusters.
    Dhandapani R; Sethuraman S; Subramanian A
    J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic application of nanoemulsions in chemotherapy.
    Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
    Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
    Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
    Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biomimetic theranostic O
    Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
    Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fe
    Li Y; Zhang H
    Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 20. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.